Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.
McDonald CR, Delfanti RL, Krishnan AP, Leyden KM, Hattangadi-Gluth JA, Seibert TM, Karunamuni R, Elbe P, Kuperman JM, Bartsch H, Piccioni DE, White NS, Dale AM, Farid N.
McDonald CR, et al. Among authors: dale am.
Neuro Oncol. 2016 Nov;18(11):1579-1590. doi: 10.1093/neuonc/now063. Epub 2016 Apr 21.
Neuro Oncol. 2016.
PMID: 27106406
Free PMC article.